US CDC Panel Recommends Some 50-59 Year-Olds For RSV Vaccination

The CDC's ACIP expanded the population for adult RSV vaccines and soon could weigh a new option for pediatrics. (Shutterstock)

More from Vaccines

More from Product Reviews